Hemizygous deficiency of Krüppel-like factor 2 augments experimental atherosclerosis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 18757824.
- Also identified by DOI 10.1161/CIRCRESAHA.108.184663 and PMC identifier 2743294.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Krüppel-like factor (KLF)2 is a central regulator of endothelial and monocyte/macrophage gene expression and function in vitro. Although the composite effects of KLF2 in these 2 cell types predict that it likely inhibits vascular inflammation, the role of KLF2 in this process in vivo is uncharacterized. In this study, we provide evidence that hemizygous deficiency of KLF2 increased diet-induced atherosclerosis in apolipoprotein E-deficient mice. Our studies highlight an important role for KLF2 in primary macrophage foam cell formation via the potential regulation of the key lipid binding protein adipocyte protein 2/fatty acid-binding protein 4. These novel observations establish that KLF2 is an atheroprotective factor.
Medical subject headings
- Apolipoproteins E
- Atherosclerosis
- Diet, Atherogenic
- Fatty Acid-Binding Proteins
- Foam Cells
- Kruppel-Like Transcription Factors